TY - JOUR
T1 - Diffusely Enlarged Uterus
T2 - Evaluation with MR Imaging
AU - Kido, Aki
AU - Togashi, Kaori
AU - Koyama, Takashi
AU - Yamaoka, Toshihide
AU - Fujiwara, Toshitaka
AU - Fujii, Shingo
PY - 2003
Y1 - 2003
N2 - Diffuse uterine enlargement is a common clinical finding. Because this abnormality can represent a physiologic manifestation, benign tumor, or malignancy, the diagnostic dilemma of a diffusely enlarged uterus can be challenging. Clinical findings can provide valuable information in regard to physiologic effects, pregnancy-related changes, and hormonal causes. Cytologic examination is essential for identification of cervical and endometrial malignancies. However, since preoperative histologic examination of myometrial lesions is not possible, preoperative distinction between benign and malignant conditions is frequently difficult. Imaging thus plays an important role in evaluation of myometrial lesions. In particular, magnetic resonance (MR) imaging allows specific diagnosis of several different lesions. Signal voids and prominent vessels at MR imaging are characteristic of vascular lesions. Adenomyosis and leiomyomas can be distinguished from other lesions with MR imaging, although a variety of unusual manifestations can be seen. MR imaging findings that allow distinction between leiomyoma and leiomyosarcoma have yet to be clearly established; however, invasion, hemorrhagic necrosis, or rapid growth is suggestive of malignancy. Endometrial stromal sarcoma tends to have distinct MR imaging features that allow differentiation from benign lesions.
AB - Diffuse uterine enlargement is a common clinical finding. Because this abnormality can represent a physiologic manifestation, benign tumor, or malignancy, the diagnostic dilemma of a diffusely enlarged uterus can be challenging. Clinical findings can provide valuable information in regard to physiologic effects, pregnancy-related changes, and hormonal causes. Cytologic examination is essential for identification of cervical and endometrial malignancies. However, since preoperative histologic examination of myometrial lesions is not possible, preoperative distinction between benign and malignant conditions is frequently difficult. Imaging thus plays an important role in evaluation of myometrial lesions. In particular, magnetic resonance (MR) imaging allows specific diagnosis of several different lesions. Signal voids and prominent vessels at MR imaging are characteristic of vascular lesions. Adenomyosis and leiomyomas can be distinguished from other lesions with MR imaging, although a variety of unusual manifestations can be seen. MR imaging findings that allow distinction between leiomyoma and leiomyosarcoma have yet to be clearly established; however, invasion, hemorrhagic necrosis, or rapid growth is suggestive of malignancy. Endometrial stromal sarcoma tends to have distinct MR imaging features that allow differentiation from benign lesions.
KW - Arteriovenous malformations, uterine, 854.494
KW - Contraceptives and contraceptive devices, 854.463, 854.64
KW - Hormones, 854.64
KW - Placenta, abnormalities, 854.8249
KW - Pregnancy, 854.8269
KW - Tamoxifen, 854.64
KW - Uterine neoplasms, diagnosis, 854.30
UR - http://www.scopus.com/inward/record.url?scp=0344392699&partnerID=8YFLogxK
U2 - 10.1148/rg.236035033
DO - 10.1148/rg.236035033
M3 - 総説
C2 - 14615554
AN - SCOPUS:0344392699
SN - 0271-5333
VL - 23
SP - 1423
EP - 1439
JO - Radiographics : a review publication of the Radiological Society of North America, Inc
JF - Radiographics : a review publication of the Radiological Society of North America, Inc
IS - 6
ER -